Article
Japan's Daiichi Sankyo gets US FDA nod for blood cancer treatment
Rating:
0.0
Views:
83
Likes:
1
Library:
1
Daiichi Sankyo said the U.S. health regulator has approved its drug for treating newly diagnosed patients suffering from an aggressive type of blood cancer, pitting the treatment against those from rivals Novartis and Astellas .
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value